- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/18 - Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
Patent holdings for IPC class C07D 333/18
Total number of patents in this class: 92
10-year publication summary
|
10
|
3
|
1
|
6
|
4
|
6
|
2
|
4
|
3
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| FUJIFILM Corporation | 28841 |
4 |
| Solutia Canada Inc | 44 |
4 |
| Merck Patent GmbH | 5856 |
3 |
| Sumitomo Chemical Company, Limited | 8997 |
3 |
| ENI S.p.A. | 1253 |
3 |
| The Institute of Cancer Research: Royal Cancer Hospital | 184 |
3 |
| Novartis AG | 11254 |
2 |
| Syngenta Participations AG | 3029 |
2 |
| Idemitsu Kosan Co., Ltd. | 4116 |
2 |
| Albemarle Corporation | 511 |
2 |
| Canbas Co., Ltd. | 21 |
2 |
| General Incorporated Association Pharma Valley Project Supporting Organization | 21 |
2 |
| JX Nippon Oil & Energy Corporation | 1010 |
2 |
| Kyulux, Inc. | 217 |
2 |
| National University Corporation Hokkaido University | 1332 |
2 |
| Nissan Chemical Industries, Ltd. | 1756 |
2 |
| Progenra, Inc. | 13 |
2 |
| Nevada Research & Innovation Corporation | 46 |
2 |
| Glaxo Group Limited | 4250 |
1 |
| Samsung Electronics Co., Ltd. | 139551 |
1 |
| Other owners | 46 |